Relationship of pro-collagen biomarkers of myocardial fibrosis with myocardial dysfunction and metabolic derangement in type 2 diabetes

被引：0
|
作者：
Jellis, C. [1 ]
Sacre, J. [1 ]
Jenkins, C. [1 ]
Haluska, B. [1 ]
Martin, J. [1 ]
Marwick, T. [2 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：933 / 933
页数：1
相关论文
共 50 条
  • [1] MYOCARDIAL DYSFUNCTION AND METABOLIC DERANGEMENT IN TYPE 2 DIABETES: RELATIONSHIP WITH PROCOLLAGEN BIOMARKERS OF MYOCARDIAL FIBROSIS
    Jellis, Christine L.
    Sacre, Julian W.
    Haluska, Brian
    Jenkins, Carly
    Marwick, Thomas H.
    Martin, Jennifer H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E860 - E860
  • [2] BIOMARKERS OF MYOCARDIAL FIBROSIS AND RENAL DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bilovol, Oleksandr M.
    Kniazkova, Iryna I.
    Kirienko, Oleksandr M.
    Bogun, Maryna, V
    Kirienko, Denis M.
    Abramova, Lilya P.
    Berezin, Alexander E.
    PHARMACOPHORE, 2020, 11 (06): : 132 - 140
  • [3] Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus
    Jin, Tao
    Fu, Xiangrui
    Liu, Ming
    An, Fengshuang
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [4] Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus
    Tao Jin
    Xiangrui Fu
    Ming Liu
    Fengshuang An
    Diabetology & Metabolic Syndrome, 15
  • [5] Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus
    Liu, Ju-Hua
    Chen, Yan
    Zhen, Zhe
    Ho, Lai-Ming
    Tsang, Anita
    Yuen, Michele
    Lam, Karen
    Tse, Hung-Fat
    Yiu, Kai-Hang
    BIOMARKERS IN MEDICINE, 2017, 11 (07) : 569 - 578
  • [6] Early signs of myocardial systolic dysfunction in patients with type 2 diabetes are strongly associated with myocardial microvascular dysfunction independent of myocardial fibrosis: a prospective cohort study
    Annemie S. Bojer
    Martin H. Sørensen
    Stine H. Madsen
    David A. Broadbent
    Sven Plein
    Peter Gæde
    Per L. Madsen
    Diabetology & Metabolic Syndrome, 16
  • [7] Early signs of myocardial systolic dysfunction in patients with type 2 diabetes are strongly associated with myocardial microvascular dysfunction independent of myocardial fibrosis: a prospective cohort study
    Bojer, Annemie S.
    Sorensen, Martin H.
    Madsen, Stine H.
    Broadbent, David A.
    Plein, Sven
    Gaede, Peter
    Madsen, Per L.
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [8] Myocardial dysfunction and cardiovascular disease in type 2 diabetes
    Ofstad, Anne Pernille
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 (04): : 271 - 281
  • [9] Myocardial Metabolic Flexibility in Complicated Type 2 Diabetes
    Jonker, Jacqueline T.
    Tjeerdema, Nathanja
    Bus, Mieke T. J.
    Lamb, Hildo J.
    Kharagjitsingh, Aan V.
    De Roos, Albert
    Romijn, Johannes A.
    Smit, Johannes W. A.
    DIABETES, 2011, 60 : A142 - A143
  • [10] Prognostic value of biomarkers of myocardial fibrosis and renal dysfunction in patients with previous myocardial infarction
    Shilyaeva, N.
    Ryabov, A.
    Shpigel, A.
    Shchukin, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 542 - 542
12345